Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism III: Nursing Management

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reviews.

Aerospace medicine and human performance·2015

Same author

Reviews.

Aerospace medicine and human performance·2015

Same author

Aeromedical decision making--it may be time for a paradigm change.

Aviation, space, and environmental medicine·2012

Same author

Irritable bowel syndrome: aeromedical considerations.

Aviation, space, and environmental medicine·2011

Same author

Celiac disease: aeromedical considerations.

Aviation, space, and environmental medicine·2008

Same author

Aviation Rulemaking Committee--Age 60 Rule: the penultimate act.

Aviation, space, and environmental medicine·2007

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Essential thrombocythemia: aeromedical considerations.

Russell B Rayman¹

¹Aerospace Medical Association, Alexandria, VA, USA. rrayman@asma.org

Aviation, Space, and Environmental Medicine

|November 17, 2009

Summary

Essential thrombocythemia, a platelet disorder, can cause blood clots or bleeding. Diagnosis involves platelet count and bone marrow examination. Aircrew and spaceflight require careful consideration due to potential complications and treatments.

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Related Experiment Videos

Last Updated: Jun 18, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Area of Science:

Hematology
Oncology
Aerospace Medicine

Background:

Essential thrombocythemia is a chronic myeloproliferative neoplasm characterized by an elevated platelet count.
This condition increases the risk of thrombotic and hemorrhagic complications.
Diagnosis relies on platelet count and bone marrow examination revealing increased megakaryocytes.

Purpose of the Study:

To summarize the key aspects of essential thrombocythemia.
To discuss diagnostic criteria and available treatments.
To outline aeromedical and spaceflight considerations for affected individuals.

Main Methods:

Literature review of essential thrombocythemia diagnosis and management.
Analysis of thrombotic and hemorrhagic risks.
Evaluation of treatment options including hydroxyurea, anagrelide, interferon alpha, and sodium salicylate.
Assessment of aeromedical and spaceflight implications.

Main Results:

Essential thrombocythemia diagnosis is confirmed by high platelet counts and bone marrow findings.
While many patients are asymptomatic, thrombotic events can affect various body systems.
Available treatments aim to manage platelet counts and reduce complication risks.

Conclusions:

Essential thrombocythemia necessitates careful management due to potential vascular complications.
Aeromedical disposition for aircrew depends on operational demands, medication tolerance, and complication history.
Disqualification from spaceflight is recommended for individuals with essential thrombocythemia.